FedEx Corporation vs Tempus AI — how do they compare? FedEx Corporation trades at $291.31 (market cap $69.04B), while Tempus AI trades at $71.1 (market cap $12.58B). The key difference: FedEx Corporation is far larger — about 5.5× Tempus AI's market cap, and FedEx Corporation pays a 1.67% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold FedEx Corporation for 87 Days and Tempus AI for 22 Days on average.
| FDX | TEM | |
|---|---|---|
Market Cap | $69.04B | $12.58B |
Volume | 1,287,367 | 7,444,569 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $339.35 | $99.28 |
52-Week Low | $180.87 | $41.55 |
Typical Hold Time | 87 Days | 22 Days |
Enterprise Value | $98.68B | $13.21B |
Dividend Yield | 1.67% | — |
Signals from Pluang's Aura AI — not financial advice
FedEx (FDX) trades at $289.04, showing minimal daily change. The stock exhibits a bearish technical signal with key support at $288 and resistance at $290. Fundamentally, the company maintains stable profitability with a net income margin of 4.68% and a P/E ratio of 15.73, while recent earnings beats in Q4 2025 and Q1 2026 highlight operational strength. Positive developments include a $300 million electric truck order and shareholder approval of executive compensation, though rising fuel prices present a near-term headwind.
The outlook for FDX is cautiously optimistic, supported by analyst consensus favoring a buy rating with a $307.55 price target. Investment appeal lies in its reasonable valuation and dividend yield, but risks include margin pressure from fuel costs, competitive intensity, and macroeconomic sensitivity. The stock's trajectory will likely hinge on execution of cost initiatives and freight demand trends.
Tempus AI (TEM) trades at $72.15, up 2.65% today, with a bullish technical signal and strong analyst support. The stock shows recent earnings beats but remains unprofitable, with a net income margin of -17.77% for 2026. Positive developments include FDA clearance for an AI product and expanded data partnerships, fueling investor optimism in the healthtech sector.
Outlook is cautiously optimistic given growth potential in AI-driven diagnostics, but high valuation (P/S 8.61) and persistent losses pose risks. Upside hinges on revenue scaling and path to profitability, with a consensus price target of $72.60 suggesting limited near-term gains from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →